Journey Medical Corp

NEW
NAS:DERM (USA)  
$ 6.62 +0.40 (+6.43%) 10:08 PM EST
At Loss
P/B:
5.87
Market Cap:
$ 182.28M
Enterprise V:
$ 180.53M
Volume:
2.11M
Avg Vol (2M):
306.00K
Trade In:
Volume:
2.11M
At Loss
Avg Vol (2M):
306.00K

Business Description

Journey Medical Corp
NAICS : 325412 SIC : 2834
ISIN : US48115J1097

Total Employee Number:

58
Description
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Name Current Vs Industry Vs History
Cash-To-Debt
1.07
Equity-to-Asset
0.34
Debt-to-Equity
0.83
Debt-to-EBITDA
-17.94
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
1.11
Distress
Grey
Safe
Beneish M-Score
-2.33
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
58.16
9-Day RSI
58.14
14-Day RSI
57.83
3-1 Month Momentum %
28.03
6-1 Month Momentum %
-22.73
12-1 Month Momentum %
-12.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.72
Quick Ratio
1.47
Cash Ratio
0.72
Days Inventory
183.16
Days Sales Outstanding
120.12
Days Payable
182.13

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-15.2
Shareholder Yield %
-5.37

Financials (Next Earnings Date:2026-08-12 Est.)

DERM's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DERM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Journey Medical Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 64.68
EPS (TTM) ($) -0.37
Beta 1.2074
3-Year Sharpe Ratio 1.14
3-Year Sortino Ratio 2.03
Volatility % 55.6
14-Day RSI 57.83
14-Day ATR ($) 0.419272
20-Day SMA ($) 6.24675
12-1 Month Momentum % -12.57
52-Week Range ($) 4.31 - 9.555
Shares Outstanding (Mil) 27.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Journey Medical Corp Filings

Filing Date Document Date Form
No Filing Data

Journey Medical Corp Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings conference call for 2026 2026-11-12 16:30 In 138 days
Third quarter earnings results for 2026 2026-11-12 In 137 days
Second quarter earnings conference call for 2026 2026-08-12 16:30 In 46 days
Second quarter earnings results for 2026 2026-08-12 In 45 days
General meeting for 2026 2026-06-24 11:00 6.70 (+5.51%)
A.G.P.’s Annual Virtual Healthcare Conference 2026-05-20 17:00 6.15 (+0.16%)
First quarter earnings conference call for 2026 2026-05-13 16:30 5.01 (+1.62%)
First quarter earnings results for 2026 2026-05-13 5.01 (+1.62%)
Annual report for 2025 2026-03-26 6.83 (-3.12%)
Fourth quarter earnings conference call for 2025 2026-03-25 16:30 6.91 (+1.17%)
Show
Entries

Journey Medical Corp Frequently Asked Questions

What is Journey Medical Corp(DERM)'s stock price today?
The current price of DERM is $6.62. The 52 week high of DERM is $9.56 and 52 week low is $4.31.
When is next earnings date of Journey Medical Corp(DERM)?
The next earnings date of Journey Medical Corp(DERM) is 2026-08-12 Est..
Does Journey Medical Corp(DERM) pay dividends? If so, how much?
Journey Medical Corp(DERM) does not pay dividend.

Articles on Journey Medical Corp

No articles.

Headlines

See More
  • 1
No news.
  • 1